C. Cummings

Refining the Amsterdam Criteria and Bethesda Guidelines: Testing Algorithms for the Prediction of Mismatch Repair Mutation Status in the Familial Cancer Clinic

Lara Lipton, Victoria Johnson, C. Cummings et al. · Journal of Clinical Oncology · 2004 · 125 citations

Tumor mutation load assessed by FoundationOne (FM1) is associated with improved efficacy of atezolizumab (atezo) in patients with advanced NSCLC

Marcin Kowanetz, Wei Zou, David S. Shames et al. · Annals of Oncology · 2016 · 48 citations · Full text

Advanced Nsclc, Medicine, Pathology +9

The views of general practitioners on community carrier screening for cystic fibrosis.

Mary Boulton, C. Cummings, R. Williamson · PubMed · 1996 · 32 citations

Analysis of somatic molecular changes, clinicopathological features, family history, and germline mutations in colorectal cancer families: evidence for efficient diagnosis of HNPCC and for the existence of distinct groups of non-HNPCC families

Victoria Johnson, Lara Lipton, C. Cummings et al. · Journal of Medical Genetics · 2005 · 20 citations · Full text

The carrier clinic: an evaluation of a novel clinic dedicated to the follow-up of <i>BRCA1</i> and <i>BRCA2</i> carriers—implications for oncogenetics practice

Elizabeth Bancroft, Imogen Locke, Audrey Ardern‐Jones et al. · Journal of Medical Genetics · 2010 · 15 citations · Full text